Boehringer Ingelheim Investigational Site

Raleigh, North Carolina

0 studies enrolling now · 3 studies all time

What they study most

Hypertension, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Tiotropium / Respimat One-Year Study — Completed
• PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) — Completed
• A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients — Completed